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RECOMBINANT PROTEIN PRODUCTION 
AND INSECT CELL CULTURE AND 
PROCESS 
ORIGIN OF THE INVENTION 
The jointly made invention described herein was made by 
employees of the United States Government and may be 
manufactured and used by or for the Government of the 
United States of America for governmental purposes without 
the payment of any royalties thereon or therefor. 
The invention described herein was also made by inven- 
tors in the performance of work under a NASA contract with 
Krug Life Sciences and a memorandum of understanding 
with Wane  University and is subject to the provisions of 
Section 305 of the National Aeronautics and Space Act of 
1958, Public Law 85-568 (72 Stat. 435; 42 U.S.C. 2457). 
RELATED APPLICATION 
This application is a continuation-in-part of U.S. appli- 
cation Ser. No. 08/062,856 entitled Recombinant Protein 
Production and Insect Cell Culture and Process filed May 
14, 1993, now abandoned 
BACKGROUND OF THE INVENTION 
In vitro cultures of animal cells are hosts for an increasing 
assortment of recombinant protein products. This is a rela- 
tively new phenomenon, beginning in the mid 1980’s. In this 
short period of time, these proteins have made a substantial 
contribution to the U.S. economic market. In the pharma- 
ceutical industry alone, biotherapies, which are primarily 
recombinant proteins, generated $1.2 billion in US. sales in 
1991 and may grow to nearly $8.0 billion in 2001 as more 
proteins become commercially available wayer, A. M., C 
& EN, Feb. 25,27 (1991)l. The market size and its capacity 
for growth demonstrate the importance of recombinant 
protein production to the fields of biotechnology and 
bioengineering. 
Recombinant proteins derived from animal cells are 
employed in a range of disciplines from agriculture to 
medicine to basic research. During the past decade in 
medicine, progress has been made in genetic engineering 
and animal-cell cultivation to produce an increasing assort- 
ment of recombinant proteins in sufEcient quantities for the 
development of new drug therapies. The proteins themselves 
can serve as therapies, or they can be used to identify and 
test chemotherapies that regulate protein function in vivo. 
Recombinant tissue plasminogen activator is an example of 
a protein therapy. It is given to patients with evolving 
myocardial infarction to dissolve coronary thrombus and 
restore blood flow to the ischemic area [Longridge, D. J., 
Foilenfant, M. J., Maxwell, M. P., Ford, A. J.. and Hughes 
B., Cardiovasc. Res., 24, 697 (1990)l. In clinical trials, 
another protein therapy, erythropoietin, has been used to 
treat anemia in patients with progressive renal failure 
[Eschbach, J. W., Kelly, M. R., Haley, N. R., Abels, R. L, and 
Adamson, J. W., N. Engl. J. Med., 321, 158 (1989)l and 
sickle cell disease [Goldberg, M. A., Brugnara, C., Dover, G. 
J., Schapira, L., Charache, S., and Bun,  H. F., N. Engl. J. 
Med., 323, 366 (1990)l. Examples of protein-regulating 
chemotherapies include enalapril, an inhibitor of 
angiotensin-converting enzyme, for the treatment of sickle 
cell disease. [F& R. J., Scheinman, J., Phillips, G., 
orringer, E., Johnson, A., and Jennette, J. C., N. Engi. J. 
Med., 326,910-915 (1992)l. A chemotherapy derived from 
azole regulated cytochrome P-450 dependent testosterone 
2 
biosynthesis [Bossche, H. V., Lauwers W., Willemsens, G., 
Cools, W, Prog. Clin. Bioi. Res., M A ,  187 (1985)l. 
At present, both procaryotes and eucaryotes are utilized as 
hosts for commercial production of recombinant proteins. 
5 The choice of one over the other is based on the structural 
complexity of the protein being produced and the desired 
yield If a protein can be produced in a biologically active 
form from either host, procaryotes are preferred they grow 
faster and express more protein than animal cells Marino, 
M. H., BioPham, July/August, 18 (1989); Bebbington, C. 
and Hentschel, C., Trends Biotechnol., 3, 314 (1985)l. 
Doubling times are in hours rather than days. Similarly, 
yields are in grm of protein per liter media rather than 
milligrams per liter. Eucaryotes are chosen as hosts when 
15 procaryotes are unable to produce functional protein 
[Marino, M. H., BioPharm, July/August, 18 (1989); 
Bebbington, C. and Hentschel, C., Trends Biotechnol., 3, 
3 14 (1985)l. This typically occurs when the protein requires 
post-translational modification (e.g., glycosylation, phos- 
2o phorylation or macromolecular assembly) to be functional. 
Bacteria cannot perform post-translational modifications at 
all; simple eucaryotes such as yeast do so to a limited extent; 
but complex eucaryotes such as animal cells, with few 
exceptions, perform the entire complement of post- 
Commercial production of recombinant proteins from 
animal cells requires that the production process be reliable, 
yielding consistent amounts of product with reproducible 
biological activity. Such stringency has been achieved in 
30 vitro from animal cells cultured in a bioreactor which 
provides a controlled environment for cell growth. 
Several bioreactor designs have been employed in the past 
for the cultivation of animal cells [Merten, 0. W., Trends 
Biotechnoi., 5, 230 (1987); Nelson, K. L., BioPham, 
35 February, 42 (1988); Tramper, J., Smit, D.. Straatman, J., 
and Vlak, J. M., Bioprocess Eng., 3, 37 (1988)l. These 
include a stirred-tank reactor, a hollow-fiber reactor con- 
taining porous fiber bundles in which cells grow, and an 
airlift reactor in which gas bubbles rise through a draft tube 
40 lifting the culture fluid to the top of the reactor where it 
returns to the bottom through the annular space between the 
draft tube and outer shell of the reactor. [See Mow et al., 
U.S. Pat. No. 5,024,947, entitled “SerumFree Media For the 
Growth on Insect Cells and Expression of Products 
45 Thereby”, issued Jun. 18, 19911. Bioreactors up to 10,000 
liters in size are used in industry for animal cells [Rhodes, 
M., Genetic Engineering News, 10, Mxch, 7 (1990)l. 
Choosing the size and type of bioreactor for a particular 
process depends on a number of factors such as market 
50 demand, cell properties and yield Hollow-fiber reactors are 
currently limited to volumes on the order of one liter 
[Cracauer et al., U.S. Pat. No. ,4,804,628, entitled “Hollow 
Fiber Cell Culture Device and Method of Operation” issued 
Feb. 14,1989; Nelson, K. L., BioPharm., March, 34 (1988)l. 
55 &lift reactors can not readily keep microcarrier cultures 
(attachment-dependent cells growing bound to beads that are 
typically 100 pm in diameter) well mixed [Merten, 0. W., 
T r e d  Biotechnol., 5,230 (1987)l. The stirred-tankreactor is 
the system of choice for many companies because of its 
60 flexibility: it can support the growth of both suspension ana 
anchorage-dependent cells, can be operated in different feed 
modes, and can be scaled up to very large volumes (10,000 
liters) [Nelson, K. L., BioPham, March, 34 (1988); Nelson, 
K L., BioPham, February, 42 (1988)l. 
In biorextors, mixing is essential for cell proliferation: it 
supplies cells with nutrients and oxygen, maintains a 
homogenous environment throughout the reactor, and pre- 
25 translational modifications. 
65 
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vents cells from settling. But in conventional bioreactors, began to express recombinant intact human plasminogen in 
mixing can also cause cell damage from sufficiently large Sf9 cells after unsuccessful attempts in vertebrate cells. 
hydrodynamic forces. In a stirred tank, for example, cell [Whitefleet-Smith, J., Rosen, E., McLinden. J., Ploplis, V. 
damage has been attributed to two mixing phenomena: A.. Fraser, M. J., Tomlinson, J. E., McLean, J. W., and 
bullr-fluid turbulence and gashiquid interfaces [O'Connor, 5 Castellino, F. J., Arch. Biochem. Biophys., 271,390 (1989)l. 
K. C. and Papoutsakis, E. T.. BiotechnoL Tech., 6, 323 In the latter, plasminogen is rapidly converted by the acti- 
(1992); Kunas, K. T. and Papoutsakis, E. T., Biofechml. vators to plasmin. Other differences include high expression 
Bioeng., 36, 476-483 (1990)l. Typically, these interfaces levels Of Protein products rw$ng from 1 to greater than 500 
arise during cultivation as a result of sparging, vortex mglliter [Marina. M. H.. B i o P h m  JulyIAugust. 18 (1989)l 
formation. turbulent eddies, fluid-wall shear gradients and and ease at which DNA can be cloned into the cells [Fraser. 
surface oxygenation. Cell damage from bulk-liquid turbu- M. J.. In Wfro Cell. Dev. BioL, 25,225 (1989); Summers. 
lence has been correlated to the ratio of the Kolmogorov- M.D. and Smith. G. E., A Manual ofMefhodrfor Baculovi- 
scale eddy size to bead diameter for microcarrier cultures rus Vectors and Insect Cell Culture Procedures, Texas 
[Cherry, R. S .  and Papoutsakis. E. T., Bioprocess Eng., 1, Agricultural Experiment Station Bulletin No. 1555 vexas A 
2 9 4 1  (1986); Croughan, M. S. ,  Hamel, J. E, and Wang, D. 15 M University, College Station,Tex.. 1988)]. both of which 
L C., Biofechnol. Bioeng., 29. 130-141 (1987)l and cell make insect cells exceptional hosts for protein production. 
diameter for suspension cultures [Kunas, K. T. and Cultivation of insect cells is difEcult particularly on a 
Papoutsakis. E. T.. Biofechnol. Bioeng., 36,476-483 (1990); large scale or at a high cell density since they are more 
McQueen, A.. MeiUloc. E., and Bailey, J. E., Biotechml. sensitive to hydrodynamic forces in a bioreactor [Wu, J., 
Letters, 9. 831 (1987)l. Damage initiates as the ratio 20 King, G., Daugulis, A. J., Faulkner, I?. Bone, D. H., and 
approaches unity and intensifies at lower values. It has been Goosen, M. F. A., Appl. Microbiol. BiofechnoL, 32, 249 
proposed that eddies of the same size or smaller than cell (1989); Tramper, J., WiUiams, J. B., and Joustra, D., Enzyme 
particles (microcarrier beads or individual cells) cause high Microb. Techno.. 8, 33 (1986)l and have a greater oxygen 
shear stresses on the cell surface. interparticle collisions and uptake rate than most vertebrate cells [Maiorella, B., Inlow, 
reactor-particle collisions [Cherry, R. S .  and Papoutsakis, E. 25 D.. Shauger, A., and Harano. D.. BioDechnology, 6, 1406 
T., Bioprocess Eng.. 1, 2 9 4 1  (1986)l. For larger eddies, (1988)l. The oxygen uptake rate has been calculated to be 
shearing and collisions are minimized as cell particles move 4xlO-l' mole cell-' hr-' for Trichoplusia ni cells 
in eddy streamlines. [Maiorella. B., Inlow, D., Shauger, A., and Harano, D., 
Because animal cells are not enclosed in a cell wall like BioDechnology, 6, 1406 (1988)l as compared to 0.1 to 
bacteria, they are susceptible to hydrodynamic forces within 30 2X10-" mole cell-' hr for typical vertebrate cells [Nelson, 
a bioreactor. Agitation, shear and other hydrodynamic phe- K. L., BioPharm., March, 34 (1988)l. Upon infection with 
nomena have a profound effect on cell morphology and baculovirus, the oxygen uptake rate for insect cells further 
physiology which can result in cell damage and death. From inaeases by upwards of 30% [Kamen, A. A., Tom, R. L., 
a morphological perspective, hydrodynamic forces alter cell Caron, A. W., Chavarie. C., Massie, B., and Archambault, J., 
shape, adhesion. membrane integrity and spreading [O'Rear, 35 Biofechnol. Bioeng., 38, 619 (1991)l. The sensitivity to 
E. A., Udden, M. M., McIntire, L. V., and Lynch E. C., hydrodynamic forces is so severe that growth of a Lepi- 
Biochim. Biophys. Acta, 691.274 (1982); Lawrence, M. B., dopteran cell line, the fall armyworm ovary Spodopteru 
McIntire, L. V., and Eskin, S .  G., Blood 70, 1284 (1987); fnrgiperda (SB), is completely inhibited in bench-scale 
Ives, C. L., Eskin, S.  G.. and McIntire. L. V.. In Wtro Cell. sparged stirred tanks or airlift bioreactors unless surfactant 
Dev. Biol. 22,500 (1986)l. These morphological changes are 40 is added to protect the cell membrane [Murhammer, D. W. 
accompanied by and related to physiological changes in and Gomhee. C. F., Biotechnol. Prog.. 6, 391 (1990)l. 
DNA synthesis, mRNA synthesis and cytoskeletal rear- The combination of enhanced respiration and hydrody- 
rangement to name a few [O'Connor, K. C. and Papoutsakis, namic sensitivity places severe constraints on cell oxygen- 
E. T., Biofechnoi. Tech., 6. 323 (1992); Diamond, S .  L., ation: sufficient oxygen must be transported to the insect 
Sharefkin, J. B., Dieffenbach, C., Frasier-Scott, D., McIntire, 45 cells for respiration without inducing hydrodynamic damage 
L. V.. and Eskin. S .  G., J. Cell. Physiol, 143, 364-371 to the cells. When the oxygen requirements of insect cells 
(1990); Sato, M., Levesque, M. J., and Nerem, R. M., are not met, the culture is adversely affected. Under these 
Arteriosclerosis, 7. 276 (1987)l. There are several mecha- conditions, the culture is hypoxic or anoxic. We have 
nisms by which these hydrodynamic effects can cause cell conducted extensive investigations of anoxic cultures of Sf9 
death, including lysis from loss of membrane integrity, 50 cells [Hugler, W., "Protein Expression of Sf9 Cells Under 
detachment of anchorage-dependent cells from surfaces, and Stress and Simulated Microgravity," Thesis, Tulane Univer- 
reduced metabolic activity [O'Connor, K. C. and sity (1994)l. Within the first three hours of anoxia, cell 
Papoutsakis, E. T., Biofechnol. Tech.. 6, 323 (1992); growth is arrested, total protein synthesis is reducedby 20%, 
Croughan, M. S. ,  Hamel, J. E, and Wang, D. I. C., Biotech- and stress proteins are induced. If anoxia is continued for 
ml Bioeng., 33,731-744 (1989); Petersen, J. E. McIntire, 55 longer periods of time, cell death is evident. Others have 
L. V.. and Papoutsakis, E. T.. J.  Biotechnol, 7,229 (1988)l. observed that hypoxia reduces the yield of recombinant 
Insect cells are distinctly different from animal cells. Very protein derived from insect cells by a factor of 5 [Scott, R.I., 
little is known about insect cell metabolism. There is a Blanchard J. H.. and Ferguson, C. H. R., Enzyme Microb. 
relatively small body of literature on the subject. Insects and Technol., 14,798 (1992)l. 
vertebrate animals are classified in totally different phylo- 60 Several different types of bioreactors have been used for 
genetic systems. Consequently, insect cells have undergone insect-cell cultivation. Most of them adequately address cell 
a metabolic evolution that was completely independent oxygenation but at the expense of the cell's hydrodynamic 
compared to animal cell metabolic evolution. Insects have a sensitivity. Stirred tanks typically oxygenate cells by spag- 
unique life cycle and, as such, have distinct cellular prop ing and impeller stirring of growth medium, generating 
d e s .  One of these is the lack of intracellular plasminogen 65 hydrodynamic forces from both the mixing and bursting air 
activators in insect cells which are present in vertebrate bubbles at gashquid interfaces. Spin-filter adapters for 
cells. These differences were highlighted when investigators stirred tanks provide bubble-free oxygenation, although 
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substantial impeller stirring is still required [Avegerinos, G. Maiorella, B., MOW, D.. Shauger, A., and Harano, D., 
C., Drapeau, D., Socolow, J. S., Mao, J.-I., Hsiao, K., and Bioflechnology, 6,1406 (1988); Godwin, G., Belisle, B., De 
Broeze, R. J., Biotechnology, 8,54 (1990)l. Airlift bioreac- Giovanni, A.. Kohler, J., Gong, T., and Wojchowski, D., In 
tors are designed to eliminate hydrodynamic damage to the Vitro, 25, 17u (1989)l. This cell line is frequently chosen 
cells from impellers as mixing is achieved by rising gas 5 because it grows more robustly than other insect cells, is an 
bubbles [Inlow et al., U.S. Pat. No. 5,024,947, entitled immortal cell line, can be adapted from attachment- 
“Serum Free Media For the Growth on Insect Cells and dependent to attachment-independent growth, is an excep- 
Expression of Products Thereby”, issued June 18, 19911. tional host for recombinant protein production as described 
This design is flawed, however, in that by eliminating one in the following paragraph, can grow in serum-free media 
source of hydrodynamic damage it increases another-air/ and is commercially available [Fraser. M. J., In vitro Cell. 
liquid interfaces. The detrimental effect of impeller mixing Dev. Biol., 25,225 (1989); Wu, J., King, G., Daugulis, A. J., 
and &/liquid interfaces on insect-cell culture has been Faulkner, P., Bone, D. H., and Goosen, M. F. A., Appl. 
documented [Murhammer, D. W. and Goochee, C. E, Bio- Microbiol. BiotechnoL, 32,249 (1989); Godwin, G., Belisle, 
technol. Prog., 6,391 (1990); Chalmers, J. J. and Bavarian, B., De Giovanni, A., Kohler, J., Gong, T., and Wojchowski, 
F. Biotechnol. Prog., 7, 151 (1991)l. 15 D., In Vitro, 25, 17a (1989)l. Individual Sf9 cells have 
TWO reactor designs that consider the hydrodynamic diameters from 10 to 20 p and can be maintained by 
sensitivity of insect cells are roller bottles and microencap following standard published protocols known to those 
sulation. In roller bottles, cells are mixed by the end-over- skilled in the art of animal cell culture with the following 
end rotation of the reactor instead of byan impeller [Mow et exceptions that are distinctly different from typical animal 
al., U.S. Pat. No. 5,024,947. entitled “SerumFree Media For 20 culture protocols: they grow optimally at 27 rather than 37’ 
the Growth on Insect Cells and Expression of Products C., external CO, is not required for growth, and the optimal 
Thereby”, issued Jun. 18, 19911. In this environment, cells pH for growth media is 6.2 instead of 7.4 [Fraser, M. J., In 
grow attached to the reactor wall rather than in suspension. Vitro Cell. Dev. Biol., 25,225 (1989); Godwin, G., Belisle, 
As such, cell densities that are achieved in roller bottles are B., De Giovanni, A., Kohler, J., Gong, T., and Wojchowski, 
far less than in suspension cultures because growth is limited 25 D., In Kho, 25, 1 7 ~  (1989)l. 
by the surface area of the reactor wall. In addition, roller Sf9 shows great promise as an animal-cell host for the 
bottles are not conducive to scale up to the large volumes production of recombinant proteins. One of the reasons is 
required for commercial cultivation. Another approach to the ease at which proteins can be cloned, expressed and 
insect-cell cultivation is to encapsulate the cells within purified relative to vertebrate animal cells. Sf9 more readily 
porous microbeads [King, G. A., Daugulis, A. J., Faulkner, 30 accepts foreign genes coding for recombinant proteins than 
F!, Bayly, D., and Goosen, M. F. A., Biotechnol. Lett., 10, many vertebrate animal cells because it is very receptive to 
683 (1988)l. This shields the cells from the hydrodynamic viral infection and replication [Bishop, D. H. L. and Possee, 
forces on the outside of the beads. The Wculty with this R. D., Adv. Gene Technol., 1,55, (1990)l. Expression levels 
design is the possibility of cell aggregation and accumula- of recombinant proteins are extremely high in Sf9 and can 
tion of waste products within the beads at high cell density. 35 approach 500 mg/liter [Webb, N. R. and Summers, M. D., 
The wastes (e.g. ammonia and lactate) are byproducts of cell Technique, 2, 173 (1990)l. The cell line performs a number 
metabolism and adversely affect cell health at high concen- of key post-translational modifications; however, they are 
trations [Petersen, J. E, McIntire, L. V., and Papoutsakis, E. not identical to those in vertebrates and, therefore, may alter 
T., Biotechol., 7, 229 (1988)l. Cell aggregation is an protein function Fraser, M. J., In vitro Cell. Dev. Biol., 25, 
important issue for both mammah ‘an and insect cells where 40 225 (1989)l. Despite this, the majority of recombinant 
hydrodynamic forces are minimized. These cell types will proteins that undergo post-translational modification in 
frequently adhere to surfaces through proteins on the cell insect cells are immunologically and functionally similar to 
surface [Ben-Ze’ev, A., Farmer, S. R., and Penman, S. Cell., their native counterparts [Fraser, M. J., In Vitro Cell. Dev. 
21,365 (1980)l. In slow turning vessels, cells can aggregate Biol., 25,225 (1989)l. In contrast to animal cell culture, Sf9 
into structures several millimeters in diameter [Baker, J. L., 45 facilitates protein purification by expressing relatively low 
Prewett, T. L., Spaulding, G. E, and Goodwin, T. J., J. Cell levels of proteases and having a high ratio of recombinant to 
Biochem., 51, 382 (1993)l. The cores of such aggregates native protein expression [Goswami, B. B. and Glazer, R. 0. 
often become hypoxic or anoxic [Coleman, C. N. Semin. BioTechniques, 10,626 (1991)l. 
Omol., 16,169 (198911. For insect cells, oxygen deprivation There has been an explosive growth in the number of 
of this type would lower recombinant proteins yields as 50 proteins that have been expressed in Sf9 with less than 10 by 
described above. 1985 to over 100 by 1990. These include P-interferon 
Developing a bioreactor environment which achieves [Smith, G. E., Summers, M. D., and Fraser, M. J., Mol. Cell. 
favorable conditions for insect-cell growth through a reduc- Bioi., 3, 2156 (1983)], interleukin-2 [Smith, G. E., Ju, G., 
tion in hydrodynamic forces is a topic of much interest today Ericson, B. L., Moschera, J., Lahm, H., Chizzonite. R., and 
and is the focal point of this invention. The invention 55 Summers, M. D., Proc. Nut. Acud. Sci. USA, 82, 8404 
described here is a specific non-animal cell culture process (1985)], chimeric plasminogen activators [Devlin, J. J., 
that incorporates both reduced hydrodynamic forces and Devlin, P. E., Clark, R., O’Rourke. E. C., Levenson, C., and 
enhanced cell oxygenation. The culture is maintained as a Mark, D. E, Bioflechology, 7,286 (1989)land macrophage 
single-cell suspension, instead of in an aggregated state. colony stimulating factor [Chiou, C. J., and Wu, M. C., FEB, 
Waste byproducts are kept at lower concentrations than in 60 259,249 (1990)lto name a few. 
conventional bioreactors. Combined these features create an Baculo*ses Serve as expression system for the pro- 
environment that improves cultivation and fundamentally duction of recombinant proteins in insect cells. These 
changes cell metabolism. viruses are pathogenic towards specific species of insects, 
Much of the cultivation and production research on insect causing cell lysis [Webb, N. R. and Summers, M. D., 
cells has been performed with Sf9 cells [Wu, J., King, G., 65 Technique, 2, 173 (1990)l. They are, and have been, a 
Daugulis, A. J., Faulkner, P., Bone. D. H., and Goosen. M. natural part of the ecosystem where they control the popu- 
F. A., Appl. Microbiol. Biotechnol., 32, 249 (1989); lation size of their hosts [Miltenburger, H. G. and Kreig, A., 
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Advances in Biotechnological Processes, 3, 291 (1984)]. 
Some 300 species of baculovirus have been isolated. They 
are nonhazardous to humans, other vertebrates and indeed 
most invertebrates. After acute exposure of baculovirus from 
Autographa californica, Mamestra brassicae and Cydia 
pomonella, NMRI mice and Chinese hamsters had no chro- 
mosomal aberrations or health disturbances [Miltenburger, 
H. G. and Kreig. A., Advances in Biotechnological 
Processes, 3,291 (1984)l. Similarly, physical examinations 
and laboratory tests faded to detect any abnormalities in 
humans given various baculoviruses orally [Heimpel. A. M. 
and Buchanan. L. K., J. Inverteb,: Pathot 9.55 (1%7)]. 
Baculoviruses are desirable alternatives to conventional 
chemical insecticides for agricultural pest control because of 
their selective pathogenicity towards targeted insects. non- 
pathogenicity towards vertebrates and compatibility with the 
ecosystem. At least three baculoviruses have been registered 
by the Environmental Protection Agency for commercial 
distribution as insecticides: the baculoviruses of Heliothis 
zea, Orgyia pseudotsugata and Lymantria dispar 
[Miltenburger, H. G. and. Kreig. A., Advances in Biotech- 
nological Processes, 3,291 (1984)]. Baculovirus has been 
successfully tested to control insect populations in Sweden, 
the Soviet Union, Italy, Canada and the United States 
[Miltenburger. H. G. and Kreig, A., Advances in Biotech- 
nological Processes, 3, 291 (1984)l. At present, chemical 
insecticides are the primary means of controlling pest popu- 
lations. Their use. however. is facing growing opposition- 
they pollute the environment, and insects may become 
resistant to their effects. It is estimated that 30% of the 
agricultural pests in the Western Hemisphere can be con- 
trolled by insect viruses [Falcon, L. A., in viral Pesticides: 
Present Knowledge and Potential Effects on Public and 
Environmenrctl Health, Summers, M. D. and Kawanishi, C. 
Y.. eds. (Health Effects Research Laboratory, Office of 
Health and Ecological Effects, U.S. Environmental Protec- 
tion Agency. Research Triangle Park, NC, lm8). p.111. This 
is a significant figure. Substituting baculovirus for its chemi- 
cal counterpart in these cases could substantially reduce the 
total amount of chemical insecticides used in the environ- 
ment. 
Recombinant protein expression in insect cells is achieved 
byviral infection or stable transformation. For the former, 
the desired gene is cloned into baculovirus at the site of the 
wild-type polyhedron gene Webb, N. R. and Summers, M. 
D., Technique, 2, 173 (1990); Bishop, D. H. L. and Possee, 
R. D.. Adv. Gene TechnoL. 1. 55, (1990)J The polyhedron 
gene is nonessential for infection or replication of baculovi- 
IUS. It is the principle component of a protein coat in 
occlusions which encapsulate virus particles. When a dele- 
tion or insertion is made in the polyhedron gene, occlusions 
fad to form Occlusion negative viruses produce distinct 
morphological differences from the wild-type virus. These 
differences enable a researcher to identify and purify a 
recombinant virus. In baculovirus, the cloned gene is under 
the control of the polyhedron promoter, a strong promoter 
which is responsible for the high expression levels of 
recombinant protein that characterize this system. Expres- 
sion of recombinant protein typically begins within 24 hours 
after viral infection and terminates after 72 hours when the 
Sf9 culture has lysed. 
Stably-transformed insect cells provide an alternate 
expression system for recombinant protein production 
[Jarvis. D. L., Fleming. J.-A. G. W., Kovacs, G. R.. 
Summers. M. D., and Guarino, L. A.. Biotechnology,, 8.950 
(1990); Cavegn, C.. Young, J., Bertrand. M.. and Bernard, A. 
R., in Animal Cell Technology: Products of Today, Prospects 
8 
for Tomorrow, Spier, R. E., GrifEths, J. B.. and Berthold. W., 
Eds. (Butterworth-Heinemann, Oxford, 1994, pp. 4349)l. 
In these cells, the desired gene is expressed continuously in 
the absence of viral infection. Stable transformation is 
5 favored over viral infection when recombinant protein pro- 
duction requires cellular processes that are compromised by 
the baculovirus. This occurs, for example. in the secretion of 
recombinant human tissue plasminogen activator from Sf9 
cells [Jarvis. D. L., Fleming, J.-A. G. W., Kovacs, G. R., 
io Summers. M. D., and Guarino. L. A., Biotechnology,, 8,950 
(1990)]. Viral infection is favored when the recombinant 
protein is cytotoxic since protein expression is transient in 
this system. 
15 SUMMARY OF THE INVENTION 
Insect cells have shown unusual promise for recombinant 
protein product. This is dependent upon a large scale pro- 
duction system that provides the proper environment. The 
subject of this invention is recombinant protein production 
2o using a unique process for insect cell culture. Higher expres- 
sion rates and greater yields that can be realized with the 
new production systems will increase the variety of protein 
products and lower their cost to consumers. This can result 
in, for example. new biotherapies to treat disease, more 
25 sensitive diagnostic agents that will detect life-threatening 
illness sooner, and natural insecticides that have greater 
species specificity. Because recombinant proteins are ger- 
mane to many disciplines, this invention will have a funda- 
mental impact in many areas of investigation. This invention 
A new process system has been discovered for in vitro 
cultivation of shear-sensitive, invertebrate cells, specifically 
insect cells, and for the production of recombinant proteins 
35 from these cells. Insect cells were cultivated in a bioreactor 
which is a horizontally rotating culture vessel designed to 
create low shear by modulating the rotation, preferably in a 
bioreactor called the High Aspect Ratio Vessel (HARV) 
described in the published patent application by the National 
4o Aeronautics and Space Administration in the Scientific and 
Technical Aerospace Reports Volume 29/Number 9, May 8, 
1991, ACC NOS. N91-17531. U.S. Sa .  No. 625,345 now 
U.S. Pat. No. 5,153,131, entitled “A Culture Vessel With 
Large Perfusion Area to Volume Ratio,” invented by David 
45 A. Wolf, Clarence F. Sams and Ray P. Schwarz and filed on 
December 11,1990 and issued Oct. 6,1992, which patent is 
incorporated by reference in its entirety in this specification. 
The present invention achieves cell culture without cell 
aggregation in the HARV or any other low-turbulence 
50 environment. Prior experience with HARV cultivation is 
characterized by animal, especially mammalian cell aggre- 
gation into three-dimensional spheroids up to several milli- 
meters in diameter. However. aggregation on this scale 
would cause hypoxia in  insect cells having high oxygen 
55 uptake rates and, thus, reduce product yield. For this 
invention, inoculation and culturing conditions were 
selected to minimize or essentially eliminate aggregation. As 
such, aggregation was negligible; insect cells grew in the 
HARV as a suspension of single cells or as aggregates of 
60 only a few cells. Under these culturing conditions, there was 
no indication of hypoxia or anoxia. This is contrary to prior 
applications of the HARV to promote cell aggregation 
particularly in lllilIIlIlliili an systems. 
The insect cells were used for production of recombinant 
65 polypeptides herein defined as any type of polypeptide, 
protein or virus. For the purposes of this invention the terms 
polypeptide and protein are not intended to limit the scope 
30 can be used for commercial protein production. 
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of production of any selected amino acid sequence. The 
insect cells are selected and transformed to include a 
selected DNA sequence encoding the desired polypeptide 
Under the terms of the Budapest Treaty on the Interna- 
tional Recognition of the Deposit of Microorganisms for the 
Purpose of Patent Procedure, ‘‘RES’’ insect cells were depos- 
ited with the American m e  Culture Collection (HCC) of 
Rockville, Md., USA, on Dec. 12, 1996, and was given 
ATCC designation number ATCC CRL-12244. 
Applicant’s co-assignees, NASA and Tulane University 
represent that the H C C  is a depository affording perma- 
nence of the deposit and ready accessibility thereto by the 
public if a patent is granted. AU restrictions on the avail- 
ability to the public of the material so deposited will be 
irrevocably removed upon the granting of a patent. The 
material will be available during the pendency of the patent 
application to one determined by the Commissioner to be 
entitled thereto under 37 C.F.R. 1.14 and 35 U.S.C. 8122. 
The deposited material will be maintained with all the care 
necessary to keep it viable and uncontaminated for a period 
of at least thirty (30) years after the date of deposit or for the 
enforceable life of the patent, whichever period is longer. 
Applicant’s co-assignees acknowledge its duty to replace the 
deposit should the depository be unable to furnish a sample 
when requested due to the condition of the deposit. The cells 
are then cultured in the HARV which is a horizontally 
rotating culture vessel designed to create low shear condi- 
tions by modulating the rotation. The insect cells cultured by 
this process recombinantly produce the selected polypeptide 
which can then be collected and purified. The DNA 
sequence encoding the desired polypeptide is introduced 
into insect cells byviral infection or stable transformation. 
For the latter, the DNA sequence is incorporated into the 
cell’s own DNA and is expressed continuously throughout 
the life cycle of the cell. The former utilizes an insect 
pathogenic virus, specifically a baculovirus, cloned with the 
selected DNA sequence. This sequence is expressed tran- 
siently in insect cells, as the virus eventually kills the cells. 
If desired, selected DNA sequences can be used in the 
transformation process that promote the expression of the 
DNA sequence encoding the polypeptide. Selective initia- 
tion methods for producing the recombinant polypeptide 
may also be utilized. For instance, a regulation sequence that 
can turn on protein production by exposure to certain 
conditions or in the presence of certain compounds can be 
included in the DNA sequence used to transform the insect 
cells. In an alternative process, the insect cells are used as 
hosts for virus production. The virus may be wild type or 
transformed. Lepidoptera cells are a prefenred cell for 
transformation, and other insect cells that can be cultured by 
the process of this invention may be used. The insect cells 
may be cultured in a HARV or other vessel prior to trans- 
formation. 
The insect cells cultured by the process of this invention 
produce a cell line with unique and unexpected character- 
istic metabolism regardless of the genetic transformation to 
produce a new cell line. The metabolically transformed 
Lepidoptera cell line of this invention has been designated 
RES. Specifically, both non-infected and baculovirus- 
infected RES utilize an alternate metabolic pathway as 
compared to their Sf9 counterparts characterized by pH 
change, glucose and amino acid consumption, and lactic 
acid production. Accordingly, transformations can be viral 
or metabolic or both. 
An alternative process of this invention utilizes an insect 
pathogenic virus to produce recombinantly the selected 
product. 
10 
polypeptide using the insect cells as a host. The preferred 
virus is a baculovirus. The virus is prepared to include the 
incorporation of the selected DNA sequence encoding the 
polypeptide. Other DNA sequences to promote or enhance 
5 the expression and production of the polypeptide may also 
be included in the incorporated DNA sequence. The insect 
cells are cultured as described herein and the selected virus 
is transferred into the culture vessel inoculating the insect 
cells. The virus infects the insect cells and uses the insect 
10 cells as a host to replicate and produce the encoded polypep- 
tide. The polypeptide may be collected and purified as 
desired. 
In the preferred process using the HARV, insect cells were 
grown in a liquid medium suspension without support 
15 matrices such as microcarrier beads. Aggregation was neg- 
ligible. In the HARV, the growth and metabolic profile for 
these insect cells were profoundly merent than those 
obtained using conventional cultivation techniques. 
Specifically, stationary phase in the HARV was extended 
20 from 24 hours to at least 7 days while cell concentration and 
viability remained in excess of 1x10’ viable cells/& and 
90%, respectively. Measurements of glucose utilization, 
lactate production, ammonia production and pH change 
indicate that HARV cultivation had a two-fold effect on cell 
25 metabolism. Less nutrients were consumed and less wastes 
were produced in stationary phase by as much as a factor of 
4 over that achieved with conventional vessels. Those nutri- 
ents that were consumed in the HARV were directed along 
different metabolic pathways as evidenced byan extreme 
30 shift in glucose utilization from consumption to production 
in lag phase and a decrease in yield coefficients by one half 
in stationary phase. These results suggest that cultivation of 
insect cells in the HARV may reduce production costs of 
cell-derived biologicals by extending production time and 
Further distinctions between the process of this invention 
and conventional cultivation were observed after insect cells 
were infected with recombinant baculovirus coding for the 
protein kgalactosidase (p-gal). Using the process of the 
40 present invention, the cultures infected at a concentration of 
1 . 3 ~ 1 6  viable cells/ml with a multiplicity of infection 
(MOI) of 10 continued to grow for a period of 35 hours after 
infection to 1 . 7 ~ 1 0 ~  while retaining a viability that exceeded 
90%. Under the same infection conditions, conventional 
45 cultivation in shaker flasks resulted in a loss in viable cell 
concentration within 24 hours after infection. In fact, viable 
cell Concentration remained higher in the HARV throughout 
the 180 hours of cultivation by approximately a factor of 2 
or greater. These higher concentrations can result in a greater 
50 yield of baculovirus and recombinant protein from the 
HARV culture. Moreover, these results are illustrative of 
alternate metabolic pathway usage. Not only does this 
represent a new process for expressing protein, but enables 
the production of pathogenic virus for use as an insecticide. 
Production of recombinant bgal using the present inven- 
tion surpassed that achieved in shaker flasks. For the infec- 
tion conditions described in the previous paragraph, the 
amount of pgal present was greater by a factor of 2 to 7 
during cultivation, resulting in a total yield of protein that 
60 ranged from 8 to 33 units of bgayml medium. A unit of 
p-gal is defined as the amount of the enzyme required to 
hydro lyze  l.Opmole/min o-nitrophenyl-P-D- 
galactopyranoside ~ (ONPG) at pH 7.3” and 37” C. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIGS. lA and 1B. FIG. 1Apowth & FIG. 1B viability 
profiles HARV cultures of RES cells (*) and shaker culture 
35 reducing medium requirements. 
55 
65 
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of Sf9 cells (0).  Experimental conditions for cultivation are ences observed in culture performance between the HARV 
described in the Detailed Description of the Invention and and shaker flask should be applicable and most likely 
are summarized in Table 1. magnified in comparisons between the HARV and more 
FIG. 2. A comparison of medium replacement in the turbulent bioreactors. 
HARV (e) versus shaker flask (0). Medium replacement is 5 To inoculate the 50 ml HARV, it was first filled with 15 
quantified as the accumulation of spent medium removed ml of medium to act as a cushion for the suspended Sf9 cells 
from each vessel. as they were pipetted into the vessel. lkenty-five milliliters 
FIGS. 3A to 3D. Intrinsic metabolic activities of HARV Of viable celldml was added next. An additional 10 
culture of RES cells and shaker culture of Sf9 cells. Nomen- ml ofrnedium was Used to fill the vessel. l k o  5-ml syringes 
clature for the two vessels is the same as in previous figures. lo half-filled with medium were attachedto the small PO* and 
Plotted are glucose utilization FIG. 3 4  pH change FIG. 3B, manipulated to remove all & bubbles from the vessel. One 
lactate production FIG. 3C and ammonia production FIG. syringe was removed the open Small Pod was and 
3D. one syringe remained attached for pressure equalization. 
bough 3, each data point represents the The vessel was screwed into its base. The initial rotation 
two measurements per culture. Measurements had uncer- the rotation to minimize turbulance while main- 
taining a cellular suspension. tainties of no more than 5% each. 
Both pH and glucose were monitored to determine the 
DETAILED DESCRWI'ION OF THE frequency of cell feeding in the HARV and shaker flask A 
INVENTION 2o Yellow Springs Instrument (YSI) Model 27 IndusMal Ana- 
detect glucose (YSI kit 2365). In the two vessels, cells were 
mdd and pH 
vessel rotation was first stopped. The culture remained 
For FIGS. 
average of four measurements from two separate cultures, l5 speed was set at 11 or 12 rpm, with adjustments made to 
Insect cells for in vitro cultivation have been produced lYZer eeUow Ohio) was to e n z m t i d Y  
and several cell lines are commerci~y 
described herein regardless of the source. The preferred cell 25 to maintain a glucose level Of 
nS 
process inc1udes using insect cells capable of culture as 
line is Lepidoptera Sf9 cells. Other cell fines include &os@ 
Cultures (S&buIy, m) or cabbage looper Trichoplusb ni 
cells including High Five available from Invitrogen Gorp. 
Corporation or American Type Culture Collection mediUnl. bubbles were from the vessel, and 
fed cell-free spent medium with fresh 
5-9 and 6-4. For medium rep1acement in the HARv? 
cells from the E~~~~~ collection of cell 
for about minutes until the the 
Pod had clarified. Conditioned medium (10 d) was 
(San Diego, Calif.) Sf9 insect cells from either Invitrogen 30 removed through the top Pod and rep1aced with fresh 
@ockville, Md.) are the preferred cell line and were culti- rotation was resumed* 
vated in the bioreactor freely suspended in serum-free Inoculation and culture conditions in the HARV were 
EX-CELL 401 Medium purchased from JRH Biosciences designed to minimize cell aggregation. Sp~cificallY, the 
(Lenexa Kans.) and maintained at 27O C. The preferred 35 vessel was inoculated with a relatively low concentration of 
bioreactor is the HARV as described above. The metab& sf9 Cells (2X1O6 viable Cell/d). This greatly reduced nucle- 
cally transformed cell line RES derived from the Sf9 cells ation of cell aggregates as the inoculum passed through a 
was cultivated in the HARV using the process of t h i s  IlaITOW Port into the m v .  In addition. ceu-cell adherence 
invention. was inhibited by a surfactant, Pluronic F-68(Sigma Chemi- 
in growth medium and 4o cal CO.. St. Louis, Mo.), in the Ex-Cell 401 medium. The 
mixed by the horizontal rotation of the vessel itself rather surfactant is present in the medium to coat the outer mem- 
than byan impeller, greatly reducing turbulent eddy forma- brane Of fragile insect Cells, Protecting them from hydrody- 
tion and reactor-cell collisions. To further reduce hydrody- namic forces during cultivation [Murhammer3  w* and 
n a h g  hy&odynamic damage to the cells at &fiquid 45 SO. it also limits interaction between surface proteins that 
interfaces. ~n addition. rotate as cause cell-cell adherence. When Sf9 cells were cultured in 
a solid body at the same angular velocity. eliminating shear the HARv in th is  akVPgation was negligible- The 
forces at th is  interface. Combined, th is  reduction in fluid grew as a suspension Of singe cells or aggregates of 
forces makes the HARV an exceptionally quiescent cultur- only a few cells- 
ing environment. In fact, the total forces acting on a unit area 50 When preferred cultivation conditions were not followed, 
of cell surface in the HARV are estimated to be less than 0.5 aggregation did occur in  the HARV. For example. inocula 
dyndcm2. The horizontal rotation of the culture vessel is containing greater than 2x1O6 viable cellslml produced 
modulated to create the low shear conditions. mically, low aggregates in non-infected cultures grown in the presence of 
shear conditions favor cell aggregation, but the insect cells Pluronic F-68. The cell structures were as large as 3 run in 
have been successfully cultured without aggregation. 55 diameter but readily dissociated into single cells with mini- 
medium served as mal agitation. vkal infection inhibited aggregation for all 
the control vessel in this study because it provides one of the cultivation conditions tested. 
most gentle f o m  of convention cultivation. The vessel was Viable cell concentrations were calculated using trypan 
mixed on a Bellco (Vineland, N.J.) orbital shaker at a blue exclusion and a hemocytometer. In addition to pH and 
rotational speed, 100 rpm. which is optimal for cell growth. 60 glucose, samples of spent medium from the HARV and 
W e  quiescent, a shaker flask generates more hydrody- shaker flask were assayed for the presence of O,, CO,, 
namic forces than the HARV. When operated at 100 rpm the lactate and ammonia. Both O2 and COz were measured with 
h u m  shear stress at the flask wall is greater than 1.0 a Coming Model 601A Blood Gas Analyzer (Ciba Coming 
dyndcm' [Cherry. R. S. and Papoutsakis. E. T., Bioprocess Diagnostics, Norwood, Md.). The YSI Model 27 Industrial 
Eng., 1.29-41 (1986)l. For comparison, most conventional 65 Analyzer for glucose measurements was also used to enzy- 
bioreactors operate near 5.0 dyne/cm2. Because shaker matically detect lactate (YSI kit 2329). Ammonia concen- 
flash generate relatively low levels of turbulence, differ- tration was determined spectrophotomebricaly by monitor- 
specifically, cells are 
n-c forces, aeration in the HARV is bubble free, e E -  Goochee. c. F., Biotechnol. Pmg., 6,391 (1990)l. In doing 
and chamber 
A 125 d shaker flask containing 50 
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ing the reductive amination of 2-oxoglutarate to glutamate in 
the presence of glutamate dehydrogenase (Sigma kit 171). 
Sf9 cells cultured in the HARV exhibit a characteristic 
metabolism that is profoundly different from that of shaker 
cultures derived from the same cell line. To emphasize this 
difference, HARV cultures of Sf9 cells upon this metabolic 
transformation have been designated as RES cells in 
memory of Russell E. Schlorff, a former NASA attorney 
who worked on this patent application and has recently 
passed away. 
FIG. 1 compares growth and viability profiles for HARV 
and shaker cultures. The lag phase was extended in the 
HARV by over 50 hours as RES cells adapted to the 
low-turbulence environment. After this time, doubling times 
in exponential phase were approximately the same in the 
two vessels, 40 to 45 hr. During lag and exponential phase, 
viability exceeded 90% in both vessels. Maximum cell 
density in the shaker flask surpassed that in the HARV by 
nearly 20% at 1.28~10' viable cells/&, however, this con- 
centration was maintained for only a limited period relative 
to the HARV. Twenty-four hours after the onset of stationary 
phase in shaker cultures, there was a noticeable reduction in 
cell viability from 92 to 82%. After an additional twenty 
hours, there was rapid cell death. For RES cultures in  the 
HARV, stationary phase was extended for at least a week 
without any loss in viability or cell concentration. 
As discussed above, these differences in culture perfor- 
mance become magnified when the HARV is compared to 
more turbulent bioreactors. Sparged stirred tanks and airlift 
bioreactors are used routinely for Sf9 cultivation. 
Murhammer, D. W. and Goochee, C. E, Biotechnol. Prog., 
6, 391 (1990) have reported maximum cell densities for 
these vessels that are substantially less than in the HARV, 1.5 
to 4 . 0 ~ 1 0 ~  total ce l lh i .  These values are on a total rather 
than a viable cell basis as reported for the HARV. Maximum 
viable cell densities would be even less. Similar values were 
reported by Ogonah, O., Shuler, M. L., and Granados, R. R., 
Biotechnol. Lett., 13, 265 (1991). 
During cultivation, the HARV provided suflicient 02/C02 
exchange for cell growth. Oxygen concentrations were com- 
parable in the two vessels: 110 to 180 mm Hg in the shaker 
flask verses 93 to 170 mm Hg in the HARV (Table 1). 
Carbon dioxide concentration, however, was substantially 
lower in the HARV by a factor of 4 on average as a result 
of more efficient removal by the bioreactor or lower pro- 
duction by the cells. FIG. 2 reveals that shaker cultures 
required more medium replacement than HARV cultures, as 
much as a factor of two times more after 275 hr of culturing. 
Despite this greater exchange of medium, the shaker con- 
tained higher waste product concentrations for lactate and 
ammonia (Table 1). Lactate concentrations did not exceed 
500 mgll in the HARV but surpassed 850 mg/l in the shaker 
flask Comparable results were obtained for ammonia-the 
shaker flask contained between 21-35 mgA; the HARV, 
21-28 mg/l. These differences in waste accumulation indi- 
cate that the low-turbulence environment of the HARV 
significantly affected cell metabolism. 
14 
TABLE 1 
SUMMARY OF CULTNATION CONDlTIONS FOR HARV 
CULTURE OF RES CELLS AND SHAKER 
CULTURE OF Sf9 CELLS 5 
Parameter value in Valw. in 
Measured unit HARV Shaker Flask 
[Cell] 
Viability 
Reactor Wlume 
Rotational Speed 
10 
[Dissolved O,] 
[Dissolved CO,] 
[Glucose] 
Lactate] 
[Ammonia] 
15 PH 
~~ 
1.0 x 106- 
1.12 x 107 
92-93 
50 
12-21 
93-170 
1.3-4.6 
5 .M.4  
100-250 
18482 
21-28 
1.0 x lo6- 
1.28 x 107 
34-97 
50 
100 
11C-180 
3.6-14.6 
5.6'6.4 
75=-250 
18-892 
21-35 
"Because of rapid nutrient consumption and waste pdwtion in shaker 
2o cultures during death phase, pH and glucose concentration fell below 5.9 and 
100 @dl, respectively. 
Glucose, pH, lactate and ammonia data are shown in 
FIGS. 3A, 3B, 3C and 3D respectively on a per cell basis so 
that intrinsic changes in metabolic activity can be easily 
25 discerned. For all four parameters measured, nutrient utili- 
zation and waste production differed dramatically in the two 
vessels. In the HARV, the rate of pH change and lactate 
production were less than in the shaker flask during lag and 
stationary phase, but approached the corresponding shaker 
30 parameters during exponential phase. The differences 
between the vessels were the greatest during the last 100 hr 
of cultivation. Here, the ratio of the shaker flask to HARV 
data exceeded a factor of 3 for pH change and 4 for lactate 
production. 
Glucose utilization and ammonia production followed a 
different trend (FIGS. 3A and 3D). In the shaker flask, 
glucose was consumed throughout cultivation. Not only was 
consumption less in the HARV, but glucose was produced 
during lag phase and the early part of exponential phase. The 
40 maximum rate of glucose production equaled 0 . 5 ~ 1 0 ~  
mgldl-cell-hr and occurred 75 hr after inoculation as RES 
cells entered exponential phase. When glucose was 
produced, ammonia production rose by a factor of two (FIG. 
3 D). When glucose was subsequently consumed in the 
45 HARV after 150 hr of cultivation, ammonia production fell 
to values comparable to those in the shaker flask Enhanced 
ammonia production during this period may reflect con- 
sumption of an alternate nutrient as an energy source, such 
as amino acids, which would liberate ammonia upon con- 
50 sumption [Kamen, A. A., Tom, R. L., Caron. A. W., 
Chavarie, C., Massie, B., and Archambault, J., Biotechnol. 
Bioeng., 38,619 (1991)l. Glucoseproduction has been noted 
by Wang, M. Y, Kwong, S., and Bentley, W. E. Biotechnol. 
Prog., 9, 355 (1993), but they did not speculate about its 
55 cause. Possibly, glucose accumulated in HARV cultures as 
RES cells consumed complex sugars such as maltose. 
Regardless of factors causing the metabolic transformation, 
the cellular processes exhibited unpredictable characteris- 
tics. 
The metabolic data presented in HG. 3 coupled with the 
medium replacement data in FIG. 2 indicate that the effects 
of HARV cultivation on cell metabolism were two fold. 
First, fewer nutrients were consumed by RES cells in the 
HARV during stationary phase. In additions, different meta- 
65 bolic pathways were utilized in the HARV as evidenced by 
glucose production and enhanced ammonia production in 
lag phase and as reflected in the yield coefficients for lactate 
35 
60 
5,637,477 
15 
and ammonia in stationary phase. From FIG. 3, the yields of 
moles lactate and ammonia produced per mole glucose 
consumed were greater than 5 for the shaker flask during the 
last 50 hr of cultivation, whereas these yields were less than 
2.5 in the HARV during the same period. When hydrody- 
namic forces are minimized as in the HARV, the data 
presented suggest that metabolic energy is directed away 
from the repair of cellular damage to other cellular processes 
and that fewer nutrients are consumed by RES cells. 
For viral infection, RES cells were exposed to a recom- 
binant Autugrahpa califumica baculovirus from Invitrogen 
Corporation. Specifically. the HARV was seeded with Sf9 
cells at a density of 0 . 7 ~ 1 0 ~  viable cells/ml. The cultivation 
protocol was followed until the cells saw a normal doubling 
time (the cell density increased from 0 . 7 ~ 1 0 ~  to 1 . 3 ~ 1 0 ~  in 
approximately 24 hours), confirming the onset of exponen- 
tial growth. The reactor was inoculated with virus at the 
onset of exponential growth in order to maximize virus 
yield. For the inoculation, 20% of the conditioned medium 
was removed and replaced with an equal volume of fresh 
medium containing the calculated amount of virus for an 
MOI (multiplicity of infection) of 10. Thereafter, the 
infected culture received a 10-20% medium change as 
needed to maintain the pH between 6.1 and 6.3 and the 
glucose concentration between 100 and 200 mgldl. The cell 
density and viability were checked daily, as the baculovirus 
is pathogenic towards Sf9 cells, causing eventual cell death 
and lysing. When the number of viable cells dropped to 10% 
of the total cell number, a maximum virus yield was reached, 
and the experiment was terminated. This transforms the 
insect cell line to include a DNA sequence encoding for a 
selected polypeptide. In this case the baculovirus and p-gal 
were used as a model system. The model system was then 
cultured in a horizontally rotating vessel modulated to create 
low shear conditions which faditatedrecombinant polypep 
tide production. 
Infected cultures were maintained in the HARV and in 
spinner flasks for 180 hours after the initial inoculation. 
During this time, there were profound differences in the 
response of the insect cells to virus infection with these two 
types of bioreactor. Both the HARV and spinner-flask cul- 
tures were infected at a concentration of 1 . 3 ~ 1 0 ~  viable 
cells/ml with a MOI of 10 as described above. The HARV 
culture grew for an unexpected period of 35 hours after 
infection to 1 . 7 ~ 1 0 ~  viable cells/d while retaining a viabil- 
ity that exceeded 90%. After this initial period of growth, 
both viability and cell concentration dropped until they 
reached 8.2% and 1.2~10' viable cells/ml, respectively, at 
the end of the experiment. In contrast. shaker cultures 
experienced a continuous reduction in viability and cell 
concentration throughout the experiment until these values 
reached 6.4% and 4 . 0 ~ 1 0 ~  viable cells/mi. It was discovered 
that over the entire 180 hours of cultivation, viable cell 
concentration remained higher in the HARV by approxi- 
mately a factor of 2 or greater. The improvement is attributed 
to the unexpected altered metabolism. Metabolism is 
focused on viral products and not diverted to the repair 
damage results from detrimental shear forces. These higher 
concentrations can result in a greater yield of baculovirus 
and recombinant proteins from the HARV culture. 
After infection with baculovirus, RES cells in the HARV 
retain a distinctive metabolic profile that distinguish them 
from Sf9 cells. Glucose utilization and change in the pH of 
conditioned medium are examples of this behavior. The pH 
of both shaker and HARV cultures changed at approximately 
the same rate during the initial 24 hours of infection: 
3.1x10-' ApH units/cell hr in shaker flasks and 2.5x10-' 
16 
ApH unitdcell hr in the HARV. For the remainder of the 
experiment in shaker flasks, pH changed at a slightly higher 
rate of 4.7x10-' ApH unitskell hr after 60 hours of infection 
and 6.0x10-' ApH unitskell hr after 180 hours. Rather than 
5 an increase. RES cultures in the HARV experience a 
decrease in the rate of pH change as infection progressed to 
0 . 8 5 ~ 1 0 - ~  ApH unitskell hr after 60 hours and 0.29xlO-' 
ApH unitskell hr after 180 hours. There are analogous data 
for glucose. Glucose utilization in the HARV was less than 
io in  shaker flasks. In the HARV. the rate at which glucose was 
consumed was reduced from a value of 1 .4~10-~  mddl cell 
hr after 35 hours of infection to 0 .67~10-~  mddl cell hr after 
an additional 54 hours. For shaker flasks, the initial rate was 
higher at 7 . 7 ~ 1 0 - ~  mg/dl cell hr after 35 hours. This rate also 
15 was lowered as the infection progressed but only to ~ . O X ~ O - ~  
mg/dl cell hr. 
To determine virus production as a function of time, 
infected cultures were titered daily using the following blue 
plaque assay from Invitrogen Corporation. Sf9 cells were 
20 seeded into four 60x15 mm animal cell culture plates at 80% 
confluency and allowed to attach for 30 to 45 minutes. The 
conditioned medium was removed from the attached cells 
after rocking the plates from side to side to pickup dead cells 
and debris. Each plate was washed with 1 ml fresh medium 
25 to remove any remaining debris. being careful not to pipet 
across the cell layer as this would have dislodged the 
attached cells. 
Ten-fold dilutions of the virus inoculum were prepared. 
For the first dilution (lo-'), 0.11 ml of cell-free virus sample 
30 was added to 0.99 ml of fresh medium. For the second 
dilution ( 0.11 ml of the first dilution was added to 0.99 
ml fresh medium. This process was continued for subse- 
quent dilutions through lo4. 
The virus dilutions were added to the prepared plates. One 
milliliter of a dilution was uniformly spread on each plate, 
making four plates, one each of lo4, lod, and lo-' 
dilutions. The virus was allowed to infect the cells for one 
hour. After one hour, the virus inoculum was drawn off. 
leaving the attached, infected cells on the plate. 
The agarose was prepared during the hour in which the 
virus was infecting the cells. For four plates, 0.38 g agarose 
was added to 12.5 ml Millipore water and autoclaved at 120" 
C. for 15 minutes. Once autoclaved, the agarose was main- 
45 tained at 40" C. The 2X Hink's TNM-FH Medium 
(containing fetal bovine serum to compensate for the tox- 
icity of the agarose, Gibco BRL Life Technologies, 
Gaithersburg, Md.) was warmed to 40" C. Three milligram 
of X-gal (Sigma) were mixed with 0.15 ml DMSO. To the 
5o warmed agarose. 0.125 ml of the X-gal-DMSO mixture and 
12.5 ml of the 2X medium were added. Each plate received 
5 ml of the agarose mixture, being careful not to dislodge the 
attached cells by pipetting across the cell layer. Once the 
agarose had solidified, the plates were stored in a plastic bag 
55 with a damp paper towel to create a humid environment to 
prevent cracking of the agarose. 
By the tenth day, blue recombinant plaques were visible. 
The virus titer was determined by taking the number of 
plaques on a plate and dividing by the dilution factor of that 
PGalactosidase @-Gal) served as a model protein to 
investigate recombinant protein production from 
baculovirus-infected insect cells in the HARV and baculovi- 
rus served as a model virus for pathogen production. This 
65 protein is frequently used in Sf9 studies since it is readily 
available and can be easily assayed. A mutant form of the 
baculovirus A. califumica (or a pathogen type in an alternate 
35 
40 
60 plate. 
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embodiment for virus production) containing the gene cod- 95 hours and was 5 U/ml. As in the HARV, the yield dropped 
ing for PGal was used as a cloning vector to introduce and to 4.3 U/ml as the experiment progressed to 180 hours. 
express the PGal gene in Sf9 cells. As the virus replicates, During the course of the experiment it was discovered that 
the PGal gene is expressed along with native viral proteins. the yield of p-gal was greater in the HARV by a factor 
The effect that the HARV has on recombinant p-Gal pro- 5 ranging between 2 to 7. 
duction is two fold; it enhances both total and intrinsic Recombinant baculovirus containing a foreign gene 
production. Because the HARV cultures insect cells to larger encoding a desired polypeptide can be generated using a 
cell densities than other conventional bioreactors, the overall modified procedure of Summers, M. D. and Smith, G. E., A 
production of the HARV culture on a per volume basis is Manual of Methods for Baculovirus Vectors and Insect Cell 
larger than in conventional systems. On an intrinsic level, Culture Procedures, Texas Agricultural Eperiment Station 
the HARV also raises the rate of recombinant protein Bulletin No. 1555 (Texas A&M University, College Station, 
synthesis through viral infectivity andor cell metabolism. Tex., 1988). First, wild-type DNA would be purified from 
As for the former, the low-turbulence environment of the intact baculovirus particles with a cesium chloriddethidium 
HARV facilitates adherence of viral particle to the cell bromide grzdient. Next, the foreign gene of interest would 
surface. As for the latter, the changes that the HARV causes 15 be cloned into pBlueBac (Invitrogen) or another baculovirus 
in cell metabolism may result in an increase in gene transfer vector. Sf9 cells would be co-transfected with both 
transcription, protein translation, post-translational pro- the recombinant transfer vector and purified wild-type viral 
cesses and protein secretion from the cell. DNA using a modification of the calciumphosphate precipi- 
The level of intracellular and extracellular recombinant tation technique. The infected cells would produce a com- 
Pgdactosidase expression was measured with a spectro- 20 bination of wild-type and recombinant virus progeny which 
photometric assay on a Thermomax microplate reader. The generate white and blue plaques, respectively, upon titering 
process for collecting the recombinantly produced polypep the virus as described previously in this section. The recom- 
tide included pipetting spent cell culture media from the binant baculovirus could be readily isolated from the 
culture vessel into a test tube. The contents of the test tube plaques and amplified in Sf9 cells to the generate large 
were then assayed for the amount of p-gal present in the 25 quantities of intact virus. 
spent media. In an alternate embodiment, spent cell culture In addition to viral infection, the HARV can be used to 
media with suspended cells was pipetted into a test tube. The produce recombinant polypeptides from insect cells by 
test tube was centrifuged at 5OOxg to pellet cells containing stable transformation. Specifically, stably-transformed Sf9 
recombinantly produced polypeptide. The supernatant was cell lines that continuously express recombinant B-gal and 
removed and the cells were lysated by standard sonication or 30 recombinant tissue plasminogen activator are available from 
detergent preparations. The lysate was suspended in buffer Texas A & M University. These cell lines could be cultured 
and assayed for recombinantly produced polypeptide, for in the HARV using the prefened process described above in 
example pgal. In an alternate embodiment the spent cell this section for non-infected Sf9 cells. Because the nutrient 
culture media containing recombinantly produced polypep requirements of the non-infected and stably-transformed Sf9 
tide or the lysate containing recombinantly produced 35 cells are very similar, we would expect that this similarity 
polypeptide can be purified by standard molecular weight extend to their growth and metabolic profiles in the HARV. 
exclusion filtration, by column chromatography. by Thus, cultivation times for the stably-transformed cells 
immunoprecipitatiodabsorption, or by centrifugation tech- should be greatly extended in the HARV because of the 
niques known in the art for the specific recombinantly prolonged stationary phase. Since these cells continuously 
produced polypeptide. Specifically, the assay determined the 40 produce recombinant polypeptides, the HARV should sig- 
amount of p-gal present based on the enzymatic conversion nificantly increase production times and product yields over 
of o-nitrophenyl-PD-galactopyranoSide (ONPG, Sigma) to that achieved in a shaker flask or other conventional 
o-nitrophenol and galactose. It measured the steady-state bioreabrs. Moreover, the HARV should reduce the cost of 
rate of ONF'G consumption at 410 nm, 37" C., and pH 7.3 production, since we have demonstrated for non-infected 
in 250 pl of solution of 0.08M NAPO,, 0.11 M 45 Sf9 cells that medium requirements are less in the HARV 
2-macaptoethanol, 0.001M MgCl,dH,O, and 0.002M than in shaker flasks. 
ONPG and 8 pl of enzymatic pgal sample. At a wavelength Stably transformed Sf9 cells containing a foreign gene 
of 410 nm, the molar extinction coefficient for ONPG is 3.5 encoding a desired polypeptide can be created with a num- 
mole cm-'. Doubling the amount of pgal present did not ber of different plasmids l i d s ,  D. L., Fleming J.-A. G. 
affect measurements of rate per unit amount of enzyme. 50 W., Kovacs, G. R., Summers, M. D., and Guarino, L. A., 
In the HARV, p-gal began to accumulate intracellularly 35 Biotechnology, 8, 950 (1990); Helgen, J. C. and Fallon, A. 
hours after the initial infection. Extracellular expression of M., In vitro Cell. Dev. BioL, 26,731 (1990)l. One of these 
the recombinant protein began 12 hours later. Using the is recombinant pUC8 (Sigma) containing the IE1 promoter 
infection protocol described above, the maximum p-gal and IE1 coding region from the baculovirus A. califomia 
concentration achieved in the HARV was 29 U/ml medium 55 The foreign gene of interest or a neomycin resistance gene 
intracellularly and 7 U/ml extracellularly after 105 and 140 would be inserted into the E1 coding region just down- 
hours of infection, respectively. By definition, a unit of p-gal stream of the E1 promoter. As described by Jarvis, D. L., 
hydrolyzes 1.0 pmoldmin ONPG at pH 7.3 and 37' C. The meming J.-A. G. W., Kovacs. G. R., Summers, M. D., and 
maximum yield of p-gal (i.e., the combination of its intra- Guarino, L. A., Biotechnology, 8, 950 (1990), Sf9 cells 
cellular and extracellular concentration) was 33 U/ml also at 60 would be co-transfection with a modification of the calcium 
105 hours. From 105 to 180 hours when the experiment was phosphate precipitation technique [Summers, M. D. and 
terminated, the pgal yield dropped to 9 U/ml possibly as the Smith, G. E., A Manual of Methods for Baculovirus Vectors 
result of denaturation or proteolytic activity. For and Insect Cell Culture Procedures, Texas Agricultural 
comparison, the maximum intracellular and extracellular Experiment Station Bulletin No. 1555 (Texas A&M 
concentrations of p-gal in shaker cultures infected under 65 University, College Station, Tex., 198S)l using a mixture of 
identical conditions were 3.7 U/ml at 95 hours and 3.2 U/ml two plasmids: one containing the neomycin resistance gene 
at 155 hours, respectively. The maximum yield occurred at and the other containing the foreign gene of interest. Then, 
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the cells would be cultivated in the presence of neomycin 
antibiotic (Gibco BRL Life Technologies). The Cells that 
grew under these conditions would contain the plasmid with 
the neomycin resistance gene. Individual colonies of cells 
from this transfected subset would be isolated and assayed 
for continuous expression of the foreign gene of interest. 
Those colonies that assayed positive would be the desired 
stably transformed Sf9 cells. 
The disclosure herein will be understood by those skilled 
in the art. It is not intended to limit the claimed invention to 
those processes and products expressly discussed. Alterna- 
tive methods to practice this invention will be recognized by 
those skilled in the art. 
We claim: 
1. Aprocess for producing a selected polypeptide in insect 
cells comprising the steps of 
(a) obtaining insect cells; 
(b) stably transforming the insect cells to include a 
selected DNA Sequence encoding a selected polypep 
tide; and 
(c) culturing the stably transformed insect cells in a 
rotating culture vessel completely filled with culture 
medium wherein said medium is oxygenated and low 
shear conditions are maintained wherein the hydrody- 
namic force is less than 0.5 dyne/cm2 during which 
time the insect cells produce the selected polypeptide, 
and wherein, while cultured in a rotating culture vessel. 
the stably transformed insect cells grow as single cells 
and have the following characteristics: (i) prolonged 
stationary phase, (2) altered metabolic profile, wherein 
the amount of utilised glucose is reduced, wherein the 
amount of lactate produced is reduced and wherein the 
amount of ammonia produced is reduced, (iii) reduced 
waste product production, and (iv) reduced nutrient 
consumption. 
2. The process of claim 1 further comprising an additional 
step (d) of collecting the selected polypeptide. 
3. The process of claim i further comprising an additional 
step of purifying the selected polypeptide. 
4. The process of claim 1 wherein the selected DNA 
sequence in step (b) further includes a DNA sequence 
encoding a promoter which specifically promotes the 
expression of the selected DNA sequence. 
5. The process of claim i wherein an additional step before 
genetic transformation in step (b) comprises culturing the 
insect cells in a rotating culture vessel completely filled with 
20 
culture medium wherein said medium is oxygenated and low 
shear conditions are maintained wherein the hydrodynamic 
force is less than 0.5 dyndcm’, wherein, while cultured in 
a rotating culture vessel, the stably transformed insect cells 
6. The process of claim 1 wherein the transformation of 
the insect cells in step @) comprises utilizing baculovirus 
containing the selected DNA sequence. 
7. The process of claim 1 wherein the insect cells in step 
8. Aprocess for producing a selectedpolypeptide in insect 
cells comprising the steps of 
(a) obtaining insect cells; 
(b) culturing the insect cells in a rotating culture vessel 
completely filled with culture medium wherein said 
medium is oxygenated and low shear conditions are 
maintained wherein the hydrodynamic force is less than 
0.5 dynelcm’ during which time the insect cells pro- 
duce the selected polypspride, and wherein, while 
cultured in a rotating culture vessel, the stably trans- 
formed insect cells grow as single cells and have the 
following characteristics: (i) prolonged stationary 
phase, (ii) altered metabolic profile, wherein the 
amount of utilized glucose is reduced, wherein the 
amount of lactate produced is reduced and wherein the 
amount of ammonia produced is reduced, (iii) reduced 
waste product production, and (iv) reduced nutrient 
consumption; 
(c) inserting a DNA sequence encoding a selected 
polypeptide into a pathogenic insect virus; 
(d) inoculating the insect cell culture of step (b) with 
sufficient amounts of the pathogenic virus of step (c) to 
infect the insect cells; 
(e) culturing the infected insect cells of step (d) for a 
period of time sufficient to produce the selected 
polypeptide encoded by the DNA Sequence; and 
5 grow as single cells. 
lo (a) are Lepidopteran cells. 
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( f )  collecting the selected polypeptide. 
9. The process of claim 8 further comprising the addi- 
tional step of purifying the polypeptide collected in step (f). 
10. The process of claim 8 wherein said insect cells are 
Lepidopteran cells. 
11. The process of claim 8 wherein the pathogenic insect 
45 virus is a baculovirus. 
* * * * *  
